Genetic testing and insurance.

Statement on Genetic Testing and Insurance

Genetic Testing and Insurance: The Complexity of Adverse Selection

Genetic testing and disability insurance: an alternative opinion.

As members of the Working Group on Genetic Testing in Disability Insurance, the authors of this alternative opinion describe their areas of disagreement with some of the conclusions in the paper written by Susan M. Wolf and Jeffrey P. Kahn.

Genetic testing for Alzheimer's and long-term care insurance.

A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced...

Genetic testing and the future of disability insurance: thinking about discrimination in the genetic age.

This article considers the future of genetic testing and disiblity insurance, and explores the potential for discrimination when using genetic information.